Nov 13, 2017 13:15 pm UTC| Business
LONDON, Nov. 13, 2017 -- The global pharmaceutical processing packaging equipment market will grow at a CAGR of 8.5% during the forecast period to reach USD 25,018.3 million by 2022, driven by growing aging population,...
Highway Holdings Limited Declares Cash Dividend
Nov 13, 2017 13:15 pm UTC| Business
HONG KONG, Nov. 13, 2017 -- Highway Holdings Limited (Nasdaq:HIHO) today announced its board of directors has declared a cash dividend of $0.06 per share on the company’s common stock. The dividend will be paid on...
Nov 13, 2017 13:11 pm UTC| Business
MONTCLAIR, N.J., Nov. 13, 2017 -- 180 Degree Capital Corp. (“180”, the “Company”) (NASDAQ:TURN), announced today that it led a $7.85 million round of financing in TheStreet, Inc. (“TST”). This financing included capital...
Nov 13, 2017 13:10 pm UTC| Business
NEW YORK, Nov. 13, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tapestry, Inc....
Nov 13, 2017 13:09 pm UTC| Business
CHANDLER, Ariz., Nov. 13, 2017 -- Microchip’s PIC18 product line has been expanded to include a new line of 8-bit microcontrollers (MCUs) that combine a Controller Area Network (CAN) bus with an extensive array of Core...
Global Kombucha Market Sales to Grow USD 2457.0 Million by 2021: Zion Market Research
Nov 13, 2017 13:07 pm UTC| Business
Sarasota, FL, Nov. 13, 2017 -- Zion Market Research has published a new report titled “Kombucha Market (Herbs Spices, Citrus, Apple, Coconut Mangoes, Flowers, and Others) by Distribution Channel (Supermarkets, Health...
Peregrine Announces Date of 2017 Annual Meeting of Stockholders
Nov 13, 2017 13:05 pm UTC| Business
TUSTIN, Calif., Nov. 13, 2017 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP) today announced that its 2017 Annual Meeting of Stockholders will be held on January 18, 2018, at 14191 Myford Road, Tustin,...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update